MedTrace Logo

Effectiveness of a Schema Therapy on Anxiety in Patients With Multiple Sclerosis

NCT04030819 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2019-07-30

No results posted yet for this study

Summary

It is a multicentric randomized and controlled study comparing a Scheme therapy program versus local practice in RRMS patients with anxiety. Patients will assist to twenty once-weekly group sessions with a 6-month follow up after the end of the programme. The main criteria is the impact of schema therapy on anxiety evaluated by the questionnaires at the end of the program and at the end of the 6-month follow-up.

Conditions

Interventions

BEHAVIORAL

schema therapy

The intervention is the schema therapy focuses on the management of anxiety and is based on self-efficacy, self-management . It consists of 20 once-weekly sessions of 90 minutes (with a 15 Min break), with homework activities between the sessions

Sponsors & Collaborators

  • Isfahan University of Medical Sciences

    collaborator OTHER

  • Paris Nanterre University

    lead OTHER

Principal Investigators

  • Marie claire GAY, full prof · university paris Nanterre

  • vahid shaygannejad, professor · Isfahan university of medical science

  • AZAM Mansourzadeh · university paris Nanterre

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2019-06-18
Completion
2019-12-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04030819 on ClinicalTrials.gov